|1.||Furukawa, Koichi: 14 articles (06/2015 - 03/2003)|
|2.||Furukawa, Keiko: 12 articles (06/2015 - 08/2005)|
|3.||Hamamura, Kazunori: 9 articles (11/2012 - 08/2005)|
|4.||Ohkawa, Yuki: 6 articles (06/2015 - 03/2008)|
|5.||Mehravi, Bita: 4 articles (12/2015 - 01/2011)|
|6.||Miyata, Maiko: 4 articles (03/2014 - 08/2008)|
|7.||Nakashima, Hideyuki: 4 articles (05/2011 - 08/2005)|
|8.||Ueda, Minoru: 4 articles (05/2011 - 08/2005)|
|9.||Yu, R K: 4 articles (03/2006 - 02/2000)|
|10.||Ardestani, Mehdi Shafiee: 3 articles (12/2015 - 01/2011)|
11/24/2015 - "Owing to the improved tumor oxygenation after the mild PTT, the combination of PTT and RT induced by WS2:Gd(3+)-PEG resulted in a remarkable synergistic effect to destroy cancer. "
09/01/2006 - "Functionalized metallofullerenes directly infused into a tumor-bearing brain provided an improved tumor delineation in comparison with the intravenously injected conventional Gd(3+) chelate. "
11/24/2015 - "In vivo cancer treatment study further uncovered that WS2:Gd(3+)-PEG could not only convert NIR light into heat for photothermal therapy (PTT) but also enhance the ionizing irradiation-induced tumor damage to boost radiation therapy (RT). "
06/01/1999 - "The present study evaluates immunization using the anti-idiotypic antibody BEC2, which mimics the ganglioside GD3 expressed on the surface of most SCLC tumors, combined with Bacillus Calmette-Guérin (BCG) as an immune adjuvant. "
12/14/2015 - "Thus, DOX-conjugated β-NaYF4:Gd(3+)/Tb(3+) nanorods combining pH-triggered drug delivery, efficient luminescence and paramagnetic properties are promising for a potential multifunctional platform for cancer therapy, biodetection, and optical and magnetic resonance imaging. "
05/15/2007 - "This study sought to determine whether giving Gd(3+) during ischemia or during reperfusion also ameliorates stunning, as these temporal relationships could help determine the clinical utility of this novel agent. "
05/15/2007 - "Treatment with Gd(3+) prior to ischemia (Group 1) had no effects on hemodynamics or regional contraction. "
05/15/2007 - "Gd(3+) (500 micromol) was given intravenously in three treatment groups:  preischemia;  during ischemia;  after reperfusion. "
05/15/2007 - "This effect appears maximal if Gd(3+) is given prior to ischemia, indicating potential utility in elective cardiac surgical procedures or percutaneous coronary interventions. "
05/15/2007 - "The lanthanide cation, gadolinium (Gd(3+)), accelerates recovery of stunned myocardium when given prior to ischemia. "
|3.||Neoplasm Metastasis (Metastasis)
10/01/2000 - "These results demonstrate that suppression of GD3-synthase expression, which results primarily in a marked decrease in the concentration of ganglioside GD3, greatly reduces cell spreading, invasion and both the incidence and growth rate of experimental metastasis of F-11 cells."
03/01/2011 - "These results show that Gd(3+)·DOTA⊂SNPs not only exhibits enhanced relaxivity and high sensitivity but also can serve as a potential tool for diagnosis of cancer metastasis."
04/08/2002 - "Defining GD3-related genes may lead to identification of clinically relevant therapeutics and to understanding of the mechanism(s) by which ganglioside GD3 affects tumor growth and metastasis."
|4.||Melanoma (Melanoma, Malignant)
04/01/2006 - "In this study, we characterized in both GD3 ganglioside-expressing Chinese hamster ovary (CHO)-K1 and SK-Mel 28 melanoma cells the intracellular trafficking and subcellular localization of the mouse monoclonal antibody to GD3, R24. "
07/15/1989 - "Therefore in vitro studies were performed to examine whether ganglioside GD3, which is highly expressed on the cell surface of cultured human melanoma cells, is being shed into the culture medium. "
01/01/2014 - "Ganglioside GD3 is highly expressed in human melanomas and enhances malignant properties of melanomas, such as cell proliferation and invasion activity. "
11/01/2012 - "Ganglioside GD3 is specifically expressed in human melanomas, and plays a role in the enhancement of malignant phenotypes of melanoma cells. "
05/15/2010 - "Melanoma is associated with high expression of ganglioside GD3, which has been targeted with modest effect in antibody therapies. "
|5.||Brain Neoplasms (Brain Tumor)
12/29/2014 - "Furthermore, it is demonstrated that TAT-Au NPs are capable of delivering Gd(3+) chelates for enhanced brain tumor imaging with a prolonged retention time of Gd(3+) when compared to the free Gd(3+) chelates. "
07/21/2009 - "In this review, we describe examples of imaging extracellular pH in brain tumors, ischemic hearts, and pancreatic islets with Gd(3+)-based pH sensors and discuss the potential of CEST and PARACEST agents as metabolic imaging sensors."
11/01/2013 - "Upconversion nanoparticles conjugated with Gd(3+) -DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts."
09/01/2006 - "The new functionalized trimetallic nitride endohedral metallofullerene species Gd(3)N@C(80)[DiPEG5000(OH)(x)] is an effective proton relaxation agent, as demonstrated with in vitro relaxivity and MR imaging studies, in infusion experiments with agarose gel and in vivo rat brain studies simulating clinical conditions of direct intraparenchymal drug delivery for the treatment of brain tumors."
12/29/2014 - "Here, a transactivator of transcription (TAT) peptide-modified gold nanoparticle platform (TAT-Au NP) with a 5 nm core size is demonstrated to be capable of crossing the BBB efficiently and delivering cargoes such as the anticancer drug doxorubicin (Dox) and Gd(3+) contrast agents to brain tumor tissues. "
|1.||Immunoglobulin G (IgG)
|3.||GD3 ganglioside (GD(3))
|6.||Ion Channels (Ion Channel)
|7.||Gadolinium DTPA (Magnevist)
|10.||Macrophage Colony-Stimulating Factor
|4.||Heterologous Transplantation (Xenotransplantation)